Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies
- PMID: 36222767
- DOI: 10.1212/CON.0000000000001151
Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies
Abstract
Purpose of review: This article summarizes the underlying biology and current diagnostic and treatment strategies for the cognitive and neuropsychiatric features of Parkinson disease (PD) and dementia with Lewy bodies (DLB).
Recent findings: Cognitive impairment and neuropsychiatric symptoms have been increasingly recognized in PD and DLB, leading to improved diagnosis and treatment strategies. While PD is most associated with and diagnosed by the presence of motor symptoms, nonmotor symptoms can often be the most debilitating for patients. Neuropsychiatric symptoms are highly prevalent nonmotor features and include cognitive impairment, depression, anxiety, psychosis, impulse control disorders, and apathy. Neuropsychiatric symptoms can be difficult to recognize and diagnose in patients with PD, in part because of comorbidity and symptom overlap with core PD features. Treatment strategies are a combination of pharmacologic and nonpharmacologic interventions used in the general population and those specific to PD. DLB is a clinical dementia syndrome, often with similar cognitive, behavioral, autonomic, and motor features as PD. Moreover, DLB has shared underlying pathophysiology with PD, as both are associated with postmortem findings of α-synuclein neuropathology at autopsy and have shared genetic risk and prodromal symptoms. DLB is clinically differentiated from PD by the presenting features of cognitive impairment in DLB, compared with the variable onset of cognitive impairment occurring 1 year or more after established motor onset in PD. Thus, diagnosis and treatment of cognitive impairment and neuropsychiatric symptoms in DLB are similar to that of PD and have important implications for maintaining patient independence and providing support for caregivers because motor, cognitive, and neuropsychiatric symptoms have an additive effect on patient functional disability.
Summary: A careful history and physical examination are often needed to accurately diagnose and treat the heterogeneous cognitive and behavioral symptoms of PD and DLB. Accurate diagnosis and treatment of neuropsychiatric symptoms and cognitive impairment in PD and DLB are important, as these are a considerable source of patient disability and caregiver burden.
Copyright © 2022 American Academy of Neurology.
Similar articles
-
Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia.Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):435-63. doi: 10.1212/CON.0000000000000309. Continuum (Minneap Minn). 2016. PMID: 27042903 Free PMC article. Review.
-
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review.
-
Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):365-70. doi: 10.1097/WAD.0b013e3181b5065d. Alzheimer Dis Assoc Disord. 2009. PMID: 19935145 Free PMC article.
-
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8. BMC Med. 2018. PMID: 29510692 Free PMC article.
-
Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset.J Geriatr Psychiatry Neurol. 2022 Jul;35(4):527-534. doi: 10.1177/08919887211023586. Epub 2021 Jun 11. J Geriatr Psychiatry Neurol. 2022. PMID: 34114509 Free PMC article.
Cited by
-
Postprandial hypotension is more common than orthostatic hypotension in older adults with dementia with lewy bodies: a cross-sectional study.Hypertens Res. 2024 Oct;47(10):2840-2846. doi: 10.1038/s41440-024-01829-x. Epub 2024 Aug 13. Hypertens Res. 2024. PMID: 39138363 Free PMC article.
-
Orthostatic hypotension in dementia with Lewy bodies: a meta-analysis of prospective studies.Clin Auton Res. 2023 Apr;33(2):133-141. doi: 10.1007/s10286-023-00933-1. Epub 2023 Mar 2. Clin Auton Res. 2023. PMID: 36862320 Review.
-
Exosomes in brain diseases: Pathogenesis and therapeutic targets.MedComm (2020). 2023 Jun 11;4(3):e287. doi: 10.1002/mco2.287. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37313330 Free PMC article. Review.
-
Lewy Body Dementia.Continuum (Minneap Minn). 2024 Dec 1;30(6):1673-1698. doi: 10.1212/CON.0000000000001496. Continuum (Minneap Minn). 2024. PMID: 39620839 Review.
-
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson's disease: clinical and therapeutic considerations.J Neural Transm (Vienna). 2023 Nov;130(11):1451-1462. doi: 10.1007/s00702-023-02684-9. Epub 2023 Aug 21. J Neural Transm (Vienna). 2023. PMID: 37603058 Review.
References
-
- Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 2015;30(12):1591–1601. doi:10.1002/mds.26424 - DOI
-
- Boeve BF, Dickson DW, Duda JE, et al. Arguing against the proposed definition changes of PD. Mov Disord 2016;31(11):1619–1622. doi:10.1002/mds.26721 - DOI
-
- Pigott K, Rick J, Xie S, et al. Longitudinal study of normal cognition in Parkinson disease. Neurology 2015;85(15):1276–1282. doi:10.1212/WNL.0000000000002001 - DOI
-
- Bäckström D, Granasen G, Domellof ME, et al. Early predictors of mortality in parkinsonism and Parkinson disease: a population-based study. Neurology 2018;91(22):e2045–e2056. doi:10.1212/WNL.0000000000006576 - DOI
-
- Matar E, Shine JM, Halliday GM, Lewis SJG. Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain 2020;143(1):31–46. doi:10.1093/brain/awz311 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials